Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Patient pain threshold 'decided by four genes'

  • Comment

Four genes may help decide a person’s pain threshold, according to US researchers.

Scientists studied the genes COMT, DRD2, DRD1, and OPRK1, in 2,721 people diagnosed with chronic pain.

“Identifying whether a person has these four genes could help doctors better understand a patient’s perception of pain”

Tobore Onojjighofia

Participants rated their perception of pain as “low”, “moderate” or “high” on a scale from one to 10.

One gene, DRD1, was 33% more prevalent in the low pain group than in the high pain group, the researchers found.

DRD2 was 25% more common among those with high pain than those with moderate pain.

People in the “moderate” group were 25% more likely to have COMT and 19% more likely to have OPRK genes than those in the “high” group.

In total, 9% of participants had a low level of pain perception, while 46% had moderate pain and 45% high pain. All were taking opioid drugs for pain relief.

Study leader Dr Tobore Onojjighofia, from the US pain management company Proove Biosciences, said: “Our study is quite significant because it provides an objective way to understand pain and why different individuals have different pain tolerance levels.

Pain threshold 'decided by genes'

“Identifying whether a person has these four genes could help doctors better understand a patient’s perception of pain,” he said.

He added: “Chronic pain can affect every other part of life. Finding genes that may be play a role in pain perception could provide a target for developing new therapies.”

The findings will be presented later this month at the annual meeting of the American Academy of Neurology in Philadelphia.

  • P4.349: “Perception of Analgesia in Narcotic Users with Chronic Pain: A Multi-Center Cross-Sectional Study Comparing Genotype to Pain VAS (P.A.I.N. Study)” Tobore Onojjighofia, Baltimore, MD
  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.